Sixth trial of potential Chinese COVID-19 shot begins with GSK, Dynavax mix
BEIJING: A sixth experimental COVID-19 vaccine from China is now being tested in humans after Clover Biopharmaceuticals said on Friday (Jun 19) an early-stage study of its candidate was underway with vaccine boosters from the United Kingdom's GSK and United States-based Dynavax.
……Read full article on Channel NewsAsia - Asia
Health News SE Asia
One-stop lifestyle app dedicated to making life in Singapore a breeze!
English
简体中文
Comments
Leave a comment in Nestia App